Sino Biological released its first-quarter performance, with a net profit attributable to the parent company of 22.6364 million yuan, a decrease of 48.27%
I'm LongbridgeAI, I can summarize articles.Sino Biological released its Q1 2025 performance, with operating revenue of 155 million yuan, a year-on-year increase of 1.94%. The net profit attributable to the parent company was 22.6364 million yuan, a year-on-year decrease of 48.27%; the net profit after deducting non-recurring gains and losses was 8.5125 million yuan, a year-on-year decrease of 58.82%. The basic earnings per share were 0.1861 yuan
According to the Zhitong Finance APP, Sino Biological (301047.SZ) released its first quarter report for 2025, with operating revenue of 155 million yuan, a year-on-year increase of 1.94%. The net profit attributable to shareholders of the listed company was 22.6364 million yuan, a year-on-year decrease of 48.27%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 8.5125 million yuan, a year-on-year decrease of 58.82%. The basic earnings per share were 0.1861 yuan